1-2 of 2
Bo Bjorkstrand, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tandem Autologous(ASCT)/ Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT.

Gosta Gahrton, MD, PhD, Bo Bjorkstrand, MD, PhD, Simona Iacobelli, Statistician, Ute Hegenbart, MD, Astrid Gruber, MD, PhD, Hildegard Greinix, MD, Liisa Volin, MD, Franco Narni, MD, Pellegrino Musto, MD, Meral Beksac, MD, Alberto Bosi, MD, Giuseppe Milone, MD, Paolo Corradini, MD, Hartmut Goldschmidt, MD, Theo de Witte, MD, Curly Morris, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2009) 114 (22): 52.
https://doi.org/10.1182/blood.V114.22.52.52
Published: 2009
Journal Articles

Long Term Follow-Up Shows No Clinical Benefit for CD34 + Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study.

Jean-Henri Bourhis, MD, Yasmina Bouko, MD, Serge Koscielny, PhD, Hildegard Greinix, MD, Gunter Derigs, MD, Gilles Salles, MD, Walter Feremans, MD, Marleen Bakkus, PhD, Jane Apperley, MD, Diana Samson, MD, Bo Bjorkstrand, MD, Dietger Niederwieser, MD, Gosta Gahrton, MD, Jose-Luis Pico, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2004) 104 (11): 921.
https://doi.org/10.1182/blood.V104.11.921.921
Published: 2004